Key result
AF catheter ablation linked to ~42% lower risk of death or stroke vs. medical therapy.
Why the study?
Catheter ablation of atrial fibrillation effectively reduces symptomatic burden, but its long-term effect on mortality and stroke remains unclear.
Does catheter ablation reduce all-cause mortality or stroke in patients with atrial fibrillation compared to medical management?
Cohort (n=54,304)
Yes
Does catheter ablation reduce all-cause mortality or stroke in patients with atrial fibrillation compared to medical management?
In a large, real-world propensity-matched cohort, catheter ablation for atrial fibrillation was associated with a significant reduction in all-cause mortality or stroke compared to medical management.
Answers are grounded in this paper and cite their sources.
Should not yet change AF ablation practice; extends real-world data on hard endpoints but leaves causality open.
OBJECTIVE: Catheter ablation of atrial fibrillation effectively reduces symptomatic burden. However, its long-term effect on mortality and stroke is unclear. We investigated if patients with atrial fibrillation who undergo catheter ablation have lower risk for all-cause mortality or stroke than patients who are managed medically. METHODS: We retrospectively included 5628 consecutive patients who underwent first-time catheter ablation for atrial fibrillation between 2008 and 2018 at three major Swedish electrophysiology units. Control individuals with an atrial fibrillation diagnosis but without previous stroke were selected from the Swedish National Patient Register, resulting in a control group of 48 676 patients. Propensity score matching was performed to produce two cohorts of equal size (n=3955) with similar baseline characteristics. The primary endpoint was a composite of all-cause mortality or stroke. Mean follow-up was 4.5±2.8 years. After propensity score matching, catheter ablation was associated with lower risk for the combined primary endpoint (HR 0.58, 95% CI 0.48 to 0.69). The result was mainly driven by a decrease in all-cause mortality (HR 0.51, 95% CI 0.41 to 0.63), with stroke reduction showing a trend in favour of catheter ablation (HR 0.75, 95% CI 0.53 to 1.07). CONCLUSIONS: Catheter ablation of atrial fibrillation was associated with a reduction in the primary endpoint of all-cause mortality or stroke. This result was driven by a marked reduction in all-cause mortality.
No takes yet. Share an insight, caveat, or question.
Åkerström et al. (2023) conducted a cohort in Atrial fibrillation (n=54,304). Catheter ablation vs. Medical management was evaluated on Composite of all-cause mortality or stroke (HR 0.58, 95% CI 0.48 to 0.69, p=<0.001). Catheter ablation of atrial fibrillation reduced the composite of all-cause mortality or stroke by 42% compared to medical management.
Synapse has enriched 10 related papers. Consider them for comparative context: